BowTiedBiotech
Subscribe
Sign in
Home
Chat
News
Market Insights
Stocks
Strategy
Books
X-Articles
The BowtiedBiotech Podcast
Archive
Leaderboard
About
Your Weekly Biotech News Fix | Ep. 939
The week of 2.16.2026
3 hrs ago
Most Popular
View all
Week 47 - Shaky Public Markets but Innovative Science Continues to Attract Capital
Nov 26, 2021
•
BowTiedBiotech
17
9
The Next Generation of Multi-Functional I&I Therapeutics | Ep. 873
Dec 7, 2025
9
4
Week 48: Always Follow the Money $$
Dec 2, 2021
•
BowTiedBiotech
12
4
Latest
Top
Discussions
The Public Playbook for Translating Science Into Therapeutics | Ep. 938
The Capital Markets Just Redefined What Translation Means
20 hrs ago
2
Helus Pharma's Make or Break Anxiety Trial | Ep. 937
HELP faces binary Phase 2 validation
Feb 18
17:09
BIOTECH MARKET RESEARCH $HELP | Ep. 936
Helus Pharma
Feb 17
2
BIOTECH MARKET RESEARCH $OLMA | Ep. 935
Olema Oncology
Feb 16
5 Hidden Themes Driving China’s Biotech Surge | Ep. 934
...and 5 Bold Predictions for What’s Next
Feb 16
Regulatory Gut Punches, GLP-1 Land Grabs, and Big Pharma Shakeups | Ep. 933
Breaking down the biggest biotech catalysts - and the risks the market may be underpricing.
Feb 14
1
17:33
Your Weekly Biotech News Fix | Ep. 932
The week of 2.9.2026
Feb 13
See all
BowTiedBiotech
Daily Biotech Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends
Subscribe
Recommendations
View all 10
Dr. EvoluSean's Toolbox
Sean Jackewicz
The Options Oracle
Edward Corona
Big Pharma Sharma
Big Pharma Sharma
BowTied Bull
BowTied Bull
Allocate’s Substack
Allocate
BowTiedBiotech
Subscribe
About
Archive
Recommendations
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
